A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 45/00 (2006.01) A61K 31/557 (2006.01) A61K 31/5585 (2006.01) A61P 13/12 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2332427
A prostaglandin EP4 receptor agonist containing as the active ingredient a prostaglandin I2 derivative. This compound binds strongly to prostaglandin EP4 receptor, which makes it useful as a pharmacological tool for clarifying physiological functions mediated by prostaglandin EP4 receptor or as a drug to be used in preventing/treating diseases in which prostaglandin EP4 receptor participates.
La présente invention concerne un agoniste du récepteur EP4 de la prostaglandine dont le principe actif est un dérivé de la prostaglandine I¿2?. Ce composé se lie fortement au récepteur EP4 de la prostaglandine, ce qui fait qu'il convient particulièrement, d'une part comme outil pharmacologique pour la mise en évidence de fonctions physologiques à médiation du récepteur EP4 de la prostaglandine, et d'autre part comme médicament de traitement ou de prévention d'affections dans lesquelles intervient le récepteur EP4 de la prostaglandine.
Hayashi Ryoji
Kumagai Hiroki
Ochi Yasuo
Smart & Biggar
Toray Industries Inc.
LandOfFree
Prostaglandin ep4 receptor agonist and treatment method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostaglandin ep4 receptor agonist and treatment method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostaglandin ep4 receptor agonist and treatment method will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2010262